As drug discovery and research efforts for COVID-19 therapies have inherited the spotlight in pharma and clinical labs around the world, interest in automated liquid handlers and robotics that can handle the workload has been increasing rapidly. This should not be surprising, as large-scale testing is needed to process thousands of patient samples every day […]
The 2020 SDi Global Assessment has been updated for the first time in the publication history of the report in response to the COVID-19 Pandemic. The 2020 SDi Global Assessment Report contains insights into the impact of the COVID-19 pandemic on the global instrumentation industry. With this completely updated report and a new add-on item, the Global Quarterly Datastream, your company can leverage […]
As COVID-19 has spread from its origins to almost every corner of the world over the past six months, it has engendered major changes around the globe. The virus has caused a global slowdown due to lockdowns, supply chain disruptions, and reduced production levels, while also stimulating a vaccine race among pharmaceuticals and biotech companies. […]
Politico reported today that CDC Director Robert Redfield said on Tuesday that he is not confident that U.S. labs have an adequate stock of the supplies used to extract genetic material from any virus in a patient’s sample — a critical step in coronavirus testing. The article goes on to quote Michael Mina, MD, PhD […]
March 30, 2020 4:03 pm
March 2, 2020 3:06 pm
February 28, 2019 7:16 pm
Strategic Directions International (SDi), part of Science and Medicine Group, is the leading business intelligence firm in the highly specialized field of analytical and life science instruments. Its client list includes virtually every major analytical instrumentation company in the United States, Europe, and Japan. Founded in 1981, the Los Angeles-based company has published hundreds of market reports and provided proprietary consulting services for a multitude of clients.